There is increasing evidence that impaired brain insulin signaling play a role in the pathogenesis of Parkinson's disease (Athauda & Foltynie, 2016; Bosco et al., 2012; Cheong et al., 2020). This evidence concerns the gene INS and Parkinson disease.